We have Ranked, Sorted and Summarized the Latest Clinical Articles.

1Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): A multicentre, randomised, double-blind phase 2 trialThe Lancet Oncology, May 22, 2015  Clinical Article
2Second-line dovitinib (TKI258) in patients with FGFR2-mutated or FGFR2-non-mutated advanced or metastatic endometrial cancer: a non-randomised, open-label, two-group, two-stage, phase 2 studyThe Lancet Oncology, May 22, 2015  Clinical Article
3Permissive underfeeding or standard enteral feeding in critically ill adultsNew England Journal of Medicine, May 22, 2015  Clinical Article  Evidence Based Medicine
4Trial of short-course antimicrobial therapy for intraabdominal infectionNew England Journal of Medicine, May 22, 2015  Clinical Article  Evidence Based Medicine
5Trends in mental health care among children and adolescentsNew England Journal of Medicine, May 22, 2015  Clinical Article  Evidence Based Medicine
6Racial and ethnic differences in breast cancer survival: mediating effect of tumor characteristics and sociodemographic and treatment factorsJournal of Clinical Oncology, May 22, 2015  Clinical Article
7Weight lifting and physical function among survivors of breast cancer: a post hoc analysis of a randomized controlled trialJournal of Clinical Oncology, May 22, 2015  Clinical Article
8Identification of a low-risk luminal a breast cancer cohort that may not benefit from breast radiotherapyJournal of Clinical Oncology, May 22, 2015  Clinical Article
9Are adaptive randomised trials or non-randomised studies the best way to address the Ebola outbreak in west Africa?The Lancet Infectious Diseases, May 22, 2015  Clinical Article
10Effect of climate change on vector-borne disease risk in the UKThe Lancet Infectious Diseases, May 22, 2015  Review Article

Show Me:

We have Ranked, Sorted and Summarized the Latest Clinical Articles.

1Oral steroids for acute sciatica produce limited improvement in function and painKaiser Permanente Health Research News, May 22, 2015
2Maternal obesity compromises babies’ immune system at time of birthThe University of California, Riverside Health News, May 22, 2015
3Drinking chamomile decreases risk of death in older Mexican American womenUniversity of Texas Medical Branch at Galveston, May 22, 2015
4Studies demonstrate risks, benefits of testosterone therapyAmerican Urological Association News, May 22, 2015
5Researchers awarded Trial of the Year for medical study to investigate cardiac arrest treatmentUniversity of Warwick Health and Medicine News, May 22, 2015
6Persistent nightmares in childhood could be linked to psychotic experiences in later adolescenceUniversity of Warwick Health and Medicine News, May 22, 2015
7Risk of sudden deafness shown to be higher in people with osteoporosisInternational Osteoporosis Foundation News, May 22, 2015
8EBV co-infection may increase malaria mortality in childhoodEmory's Woodruff Health Sciences Center News, May 22, 2015
9When it comes to hearing, diet may trump noise exposureUF Health, May 22, 2015
10UAB study shows that injury rates from wearing high-heeled shoes have doubledUAB Medicine, May 22, 2015

Show Me:

Soluble TNF receptor II increased in MS patients

As reported in the Journal of Neuroimmunology, soluble tumor necrosis factor receptor II levels are increased in patients with untreated multiple sclerosis (n-161) compared to healthy controls (n=46), and the levels increased over a 2-year follow-up, but were not associated with the severity of disability.

Vildegliptin superior to glimepiride when added to metformin

As reported in Metabolism, addition of vildegliptin (50 mg bid) to metformin in T2DM patients inadequately controlled on metformin alone was superior to the addition of glimepiride (2 mg tid) to metformin. Patients on the vildegliptin + metformin regimen lost more weight, had an improved lipid profile, had increased insulin sensitivity, and decreased post-prandial lipemia and insulinemia compared to patients on the glimepiride + metformin regimen.

Pantothenic acid effective for acne

As reported in Dermatology and Therapy, a pantothenic acid-based dietary supplement for 12 weeks reduced the total lesion count, number of inflammatory lesions, and DLQI in patients with mild-to-moderate acne (n=41) compared to placebo.

Are YOU the Smartest Doc in America?

The Smartest Doc from MDLinx keeps you current with a competitive edge, pitting colleagues against one other for the title of The Smartest Doc in America.

Take the Challenge

Be Ready for Upcoming 2015 Board Exams!

Be prepared for board reviews with confidence with 1000s of board exam style questions. Prepare Here